15.03.2017 09:13

Blockchain Invest DAC supports EverdreamSoft

Blockchain Invest, founded by pioneers of cryptocurrencies investments, acquires around 500.000 BitCrystals, tradable digital assets which act as the game-fuel and premium currency in the games of EverdreamSoft. The transaction is worth about USD100’000. The funds will be used for the further development of EverdreamSoft's game Spells of Genesis.


14.03.2017 15:02

Alibaba invests in WayRay

WayRay is a Swiss developer of a holographic augmented reality technology for internet-connected cars. The company raised US$18 million funding in round led by Alibaba and SAIC.

14.03.2017 15:01

Hot drone start-ups looking for investors

Companies such as Flyability and Fotokite are causing stirs around the world on a regularly basis. Know these start-ups present at the 34th SICTIC Investor Day together with five other selected startups specialising in unmanned aerial vehicles, drone and traveltech such as Skypull, Nezasa and Open Stratosphere on March 28th in Geneva.


13.03.2017 14:50

Kizy Tracking announces a Series A funding

Kizy Tracking’s low cost B2B tracking system is successful: revenues tripled in 2016. The company will use the funds from the financing round to launch its new generation tracker and platform and accelerate international growth.


08.03.2017 13:15

10'000 francs suisses pour soutenir un projet jurassien novateur

Le CCJE - Conseil Consultatif des Jurassiens de l’Extérieur - lance un appel à candidatures pour la 9e édition de son prix qui sera attribué à l'automne 2017. 


07.03.2017 14:34

Creaholic and Swisscom are creating an innovation center in Biel-Bienne

Creaholic and Swisscom are joining forces. On May 1, 2017, approximately 25 employees from the Swisscom Human Centered Design (HCD) department will move to Creaholic. Swisscom is acquiring a five per cent stake in Creaholic and the two teams will work closely together to exploit their combined expertise.

07.03.2017 14:30

Dirigé par une femme, Debiopharm Innovation Fund investit dans les smart datas

Debiopharm Diagnostics SA, le fonds d’investissement stratégique de Debiopharm GroupTM, a annoncé sa nouvelle stratégie et son changement de nom pour devenir Debiopharm Innovation Fund SA à compter d’aujourd’hui. En vue d’accélérer les innovations qui améliorent radicalement le développement des produits thérapeutiques et le traitement des patients, la société, dirigée par Tanja Dowe, élargit l’éventail de ses investissements au- delà du diagnostic pour inclure le smart data et les produits thérapeutiques. 

Show All


05.04.2017 09:30 - 18:00

54th Swiss Venture Day — reloaded — Zurich ewz-Unterwerk Selnau Selnaustrasse 25 8001 Zürich, Schweiz


Show All


28.03.2017 12:00 - 14:00

Valuation of emerging life sciences companies Biopôle IV. Route de la Corniche 3, Floor -1, Room 1

Top viewed

Show All





Evidence of great potential